During a weekly journal club, an attending physician presents a recently published multicenter, double-blind trial evaluating a novel monoclonal antibody for the prevention of severe asthma exacerbations. The trial enrolled 2,000 patients, who were assigned in a 1:1 ratio to receive either the new drug or a placebo.
Over a 1-year follow-up period, 150 patients in the placebo group experienced a severe exacerbation, compared to 107 patients in the treatment group. The confidence interval for the absolute risk reduction was reported as to .
The attending states: "This drug is highly effective. It reduces the risk of exacerbations by roughly . Therefore, we only need to treat 4 patients to prevent one severe exacerbation. Furthermore, the results are statistically significant because the confidence interval for the risk difference is entirely above zero."
Which of the following statements accurately identifies the true Number Needed to Treat (NNT) and the primary conceptual error made by the attending?
- The true NNT is 24; the attending incorrectly calculated the NNT by taking the reciprocal of the relative risk reduction instead of the absolute risk reduction.Answer
- BThe true NNT is 23; the attending incorrectly calculated the NNT by taking the reciprocal of the relative risk reduction instead of the absolute risk reduction.
- CThe true NNT is 4; the attending correctly calculated the NNT but incorrectly claimed statistical significance, as the confidence interval for an absolute difference must not cross 1.
- DThe true NNT is 8; the attending incorrectly calculated the overall study incidence rather than comparing the individual group event rates.
- EThe true NNT is 10; the attending incorrectly calculated the NNT by taking the reciprocal of the experimental event rate instead of the absolute risk reduction.